A 12-year survey of methicillin-resistant Staphylococcus aureus infections in Greece: ST80-IV epidemic? E. Drougka, A. Foka, A. Liakopoulos, A. Doudoulakakis, E. Jelastopulu, V. Chini, A. Spiliopoulou, S. Levidiotou, T. Panagea, A. Vogiatzi, E. Lebessi, E. Petinaki, I. Spiliopoulou Clinical Microbiology and Infection Volume 20, Issue 11, Pages O796-O803 (November 2014) DOI: 10.1111/1469-0691.12624 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 Annual percentage of methicillin-resistant Staphylococcus aureus (MRSA) among S. aureus infections in all participating hospitals. AKCH, ‘P. & A. Kyriakou’ Kyriakou Children's Hospital; GCHP, General Children's Hospital Pentelis; KHP, Karamandaneion Children's Hospital of Patras; UGHP, University General Hospital of Patras; UHI, University Hospital of Ioannina; UHL, University Hospital of Larissa. Clinical Microbiology and Infection 2014 20, O796-O803DOI: (10.1111/1469-0691.12624) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 2 Antibiotic resistance patterns among community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and healthcare-associated methicillin-resistant S. aureus (HA-MRSA), as determined with the disk diffusion method. KAN, kanamycin; FUS, fusidic acid; E, erythromycin; CC, clindamycin; TOB, tobramycin; RA, rifampicin; GM, gentamicin; CIP, ciprofloxacin; SXT, sulphamethoxazole–trimethoprim. Clinical Microbiology and Infection 2014 20, O796-O803DOI: (10.1111/1469-0691.12624) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 3 Clonal distribution of methicillin-resistant Staphylococcus aureus isolates recovered from patients admitted to the participating tertiary-care hospitals in Greece, from 2001 to 2012. Clinical Microbiology and Infection 2014 20, O796-O803DOI: (10.1111/1469-0691.12624) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions